论文部分内容阅读
目的观察促性腺激素释放激素激动剂(GnRH-a)结合反向添加治疗法治疗子宫内膜异位症术后复发的临床疗效。方法 120例子宫内膜异位症术后患者分为二组,观察组应用GnRH-a结合反向添加治疗法(肌内注射GnRH-a,同时口服7-甲基异炔诺酮);对照组单用GnRH-a(口服孕三烯酮)。观察其症状、体征和盆腔超声检查,评价药物疗效。结果二种用药方案均能有效预防子宫内膜异位症术后复发,但GnRH-a结合反向添加治疗法副作用小,给药方便,与孕三烯酮相比差异有统计学意义(P<0.05)。结论 GnRH-a结合反向添加治疗法用于子宫内膜异位症术后辅助药物治疗,毒副作用小,有较高的临床使用价值。
Objective To observe the clinical efficacy of GnRH-a combined with reverse addition therapy in the treatment of postoperative recurrence of endometriosis. Methods One hundred and twenty patients with endometriosis were divided into two groups. The observation group was treated with GnRH-a combined with reverse addition therapy (intramuscular injection of GnRH-a and oral 7-methyl-norethindrone) Group used alone GnRH-a (gestrinone). Observation of symptoms, signs and pelvic ultrasound examination, evaluation of drug efficacy. Results Both of the two regimens could effectively prevent postoperative recurrence of endometriosis. However, the side effects of GnRH-a combined with reverse addition therapy were small and convenient for administration, and the difference was statistically significant compared with gestrinone (P <0.05). Conclusion GnRH-a combined with reverse addition therapy for postoperative adjuvant drug treatment of endometriosis, toxic side effects, a higher clinical value.